Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial

Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial

Background: Despite the reduced quality of life in patients with recurrent vasovagal syncope (VVS), pharmacologic treatment options remain limited. Studies indicate that norepinephrine reuptake inhibition reduces tilt-induced syncope/pre-syncope. This study aimed to evaluate the effects of atomoxeti...

Full description

Bibliographic Details
Main Authors: Masih Tajdini, Arya Aminorroaya, Hamed Tavolinejad, Saeed Tofighi, Arash Jalali, Saeed Sadeghian, Ali Vasheghani-Farahani, Somayeh Yadangi, Nazila Shahmansouri, Shahin Akhondzadeh, Ali Bozorgi
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Syncope, Vasovagal
Syncope
Atomoxetine hydrochloride
Atomoxetine
Norepinephrine reuptake inhibition
Randomized controlled trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906721000774

Internet

http://www.sciencedirect.com/science/article/pii/S2352906721000774

Similar Items